Clorox Company (CLX) shared a mixed bag of updates, with several new developments and financial updates that might impact CLX's market performance. The company announced its
CFO Kevin Jacobsen's retirement, with
Luc Bellet named as the new CFO. Clorox's pre-Q3 earnings had varying reactions, with some suggesting it's time to accumulate shares. The company observed notable changes in
UBS Holdings, and analysts expect a decline in its earnings. However, an opposing bullish case theory exists for the firm too. Despite bear-case pricing, there's still a lack of safety margin. Renowned investor
Jim Cramer recommended CLX as a good investment, but also noted the company's under pressure. With
81% institutional ownership, CLX remains a favorite amongst big institutions and hedge funds. Future plans include a Q3 webcast in May and some dismal Q1 results amid weak earnings. The company is prepared for an upcoming
Q2 earnings report, while also announcing divestiture of its
Better Health VMS business. Among other news, Clorox completed a partnership with M2030 to advance supply chain climate action, was named 2024 Safer Choice Partner of the Year by EPA, and announced election of
Stephen Bratspies and Pierre Breber to its board of directors.
Clorox Company CLX News Analytics from Thu, 01 Aug 2024 07:00:00 GMT to Fri, 02 May 2025 16:21:00 GMT -
Rating 2
- Innovation -1
- Information 5
- Rumor -5
